AKARI THERAPEUTICS PLC's ticker is AKTX and the CUSIP is 00972G108. A total of 14 filers reported holding AKARI THERAPEUTICS PLC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $1,000 | -99.6% | 1,027 | -99.2% | 0.00% | – |
Q2 2019 | $266,000 | +291.2% | 132,000 | +594.7% | 0.00% | – |
Q1 2019 | $68,000 | +423.1% | 19,000 | +493.8% | 0.00% | – |
Q4 2017 | $13,000 | -59.4% | 3,200 | -39.6% | 0.00% | – |
Q3 2017 | $32,000 | +433.3% | 5,300 | +278.6% | 0.00% | – |
Q2 2017 | $6,000 | -97.7% | 1,400 | -94.0% | 0.00% | – |
Q1 2017 | $258,000 | +57.3% | 23,387 | 0.0% | 0.00% | – |
Q4 2016 | $164,000 | -17.6% | 23,387 | 0.0% | 0.00% | – |
Q3 2016 | $199,000 | -36.8% | 23,387 | 0.0% | 0.00% | – |
Q2 2016 | $315,000 | +34.0% | 23,387 | 0.0% | 0.00% | – |
Q1 2016 | $235,000 | -17.8% | 23,387 | +18.2% | 0.00% | – |
Q4 2015 | $286,000 | – | 19,787 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VHCP Management II, LLC | 369,490 | $3,144,000 | 1.61% |
Vivo Capital, LLC | 527,842 | $4,492,000 | 1.40% |
VHCP Management, LLC | 158,352 | $1,348,000 | 1.33% |
Foresite Capital Management III, LLC | 197,072 | $1,677,000 | 0.78% |
Boxer Capital, LLC | 139,899 | $1,191,000 | 0.53% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,150,700 | $9,792,000 | 0.46% |
NEA Management Company, LLC | 452,167 | $3,848,000 | 0.17% |
RA Capital Management | 114,039 | $970,000 | 0.10% |
ACUTA CAPITAL PARTNERS, LLC | 23,169 | $197,000 | 0.07% |
QVT Financial LP | 263,921 | $1,833,000 | 0.07% |